Acutaas Chemicals Q4 FY26: PAT Surges 114%, Revenue at ₹4,328 Mn
Acutaas Chemicals delivered outstanding Q4 FY26 performance with net profit jumping 114.1% to ₹1,343 million and revenue reaching ₹4,328 million, up 40.3% year-on-year. The company's EBITDA margin expanded significantly to 42.4% from 27.5%, while full-year FY26 revenue grew 33.0% to ₹13,394 million with PAT increasing 122.2% to ₹3,564 million. The Board recommended a final dividend of ₹2.5 per share and published the audited results in Financial Express newspapers on May 1, 2026, ensuring regulatory compliance.

*this image is generated using AI for illustrative purposes only.
Acutaas Chemicals Limited announced robust financial results for the quarter ended March 31, 2026, demonstrating significant growth across key performance metrics. The company reported Q4 net profit of ₹1,343 million compared to ₹627 million in the same period last year, while revenue reached ₹4,328 million versus ₹3,085 million year-on-year, marking substantial growth in both profitability and top-line performance.
Strong Financial Performance in Q4
The company delivered exceptional financial results with profit after tax (PAT) reaching ₹1,343 million, representing a remarkable 114.1% growth compared to the previous year's ₹627 million. The revenue performance was equally impressive, with Q4 revenue of ₹4,328 million showing strong year-on-year growth from ₹3,085 million in the corresponding quarter of the previous year.
| Key Financial Metrics: | Q4 Current Year | Q4 Previous Year | Growth |
|---|---|---|---|
| Net Profit: | ₹1,343 million | ₹627 million | 114.1% increase |
| Revenue: | ₹4,328 million | ₹3,085 million | 40.3% growth |
| EBITDA: | ₹1,835 million | ₹850 million | 116.0% increase |
| EBITDA Margin: | 42.4% | 27.5% | 1490 bps expansion |
EBITDA Performance and Margin Expansion
The company's operational efficiency showed remarkable improvement with EBITDA reaching ₹1,835 million compared to ₹850 million in the previous year. More notably, the EBITDA margin expanded significantly to 42.4% from 27.5% year-on-year, indicating strong cost management and operational leverage. This substantial margin expansion demonstrates the company's ability to optimize its operations while scaling revenue growth.
FY26 Full Year Performance
For the full fiscal year FY26, the company reported total revenue of ₹13,394 million, up 33.0% from ₹10,069 million in FY25. PAT for FY26 reached ₹3,564 million, a 122.2% increase from ₹1,604 million in the previous year. EBITDA for the year stood at ₹4,804 million with an EBITDA margin of 35.9%, compared to ₹2,321 million and 23.0% respectively in FY25.
| FY26 Financial Metrics: | FY26 | FY25 | Growth |
|---|---|---|---|
| Revenue: | ₹13,394 million | ₹10,069 million | 33.0% |
| PAT: | ₹3,564 million | ₹1,604 million | 122.2% |
| EBITDA: | ₹4,804 million | ₹2,321 million | 107.0% |
| PAT Margin: | 26.6% | 15.9% | 1070 bps |
Official Board Meeting and Dividend Declaration
In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors at their meeting held on April 30, 2026, recommended a final dividend of ₹2.5 per equity share at the rate of 50% on the face value of ₹5 per share. The dividend is subject to deduction of tax, if any, and requires confirmation by shareholders in the ensuing 19th Annual General Meeting. Company Secretary CS Ekta Kumari Srivastava provided the official intimation to both BSE and NSE exchanges.
| Regulatory Details: | Information |
|---|---|
| Meeting Date: | April 30, 2026 |
| Regulation: | SEBI Regulation 30 |
| Total Equity Shares: | 8,18,71,122 |
| Share Face Value: | ₹5 each |
| Dividend Rate: | 50% |
| Final Dividend: | ₹2.5 per equity share |
Regulatory Compliance and Newspaper Publication
Following the board meeting outcomes, Acutaas Chemicals published its audited financial results for Q4 and FY26 in newspapers on May 1, 2026, in compliance with Regulation 30 & 47 of SEBI regulations. The results were published in Financial Express All India editions (English) and Financial Express Ahmedabad edition (Gujarati) newspapers, ensuring proper disclosure to stakeholders. Company Secretary CS Ekta Kumari Srivastava confirmed the newspaper publication through official intimation to BSE and NSE exchanges.
Auditor Appointments and Material Subsidiary
The Board appointed M/s Chirag Vallabhhai Vekariya & Co., a Cost and Management Accountants firm (Firm Registration No. 001422), as the Cost Auditors for FY 2026-27. Additionally, M/s K. C Mehta & Co. LLP., a Chartered Accountants firm (Firm Registration No. 106237W), was appointed as the Internal Auditors for FY 2026-27. In accordance with the Company's "Policy for Determination of Material Subsidiaries," Indichem INC has been identified as a Material Subsidiary based on the latest audited consolidated financial statements.
Management Outlook
Executive Chairman and Managing Director Mr. Naresh Patel expressed confidence in delivering 25% revenue growth in FY27. The company's strategy focuses on building a diversified chemicals business across three high-growth verticals - Battery Chemicals, Semiconductors, and Pharmaceutical CDMO. The record date, book closure dates, and dividend pay-out date for the final dividend shall be intimated in due course of time.
Historical Stock Returns for Acutaas Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.80% | +8.42% | +26.71% | +70.10% | +154.77% | +549.16% |
Can Acutaas Chemicals sustain its exceptional 42.4% EBITDA margins in FY27 amid potential raw material cost pressures and competitive dynamics?
How will the company's expansion into battery chemicals and semiconductors position it to capitalize on India's growing electric vehicle and electronics manufacturing sectors?
What specific strategies will Acutaas employ to achieve the ambitious 25% revenue growth target for FY27 given the high base effect from FY26's strong performance?

































